Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors

Nom du journal : Neuro Oncol

Année : 2021

Volume : noab274

Auteurs: De La Cuesta E, Drilon A, Chung HC, Geoerger B, Italiano A, Doz F, van Tilburg CM, Hojgaard M, Ora I, Boni V, Capra M, Chisholm J, DuBois SG, Gallego-Melcon S, Gerber NU, Goto H, Grilley-Olson JE, Hansford JR, Hong DS, Kang HJ, Nysom K, Thorwarth A, Stefanowicz J, Tahara M, Ziegler DS, Gavrilovic IT, Norenberg R, Dima L, Laetsch TW, Perreault S,